<HashMap><database>biostudies-literature</database><scores/><additional><submitter>D'Oliviera A</submitter><funding>Agence Nationale de la Recherche</funding><funding>French Research Agency on HIV and Emerging Infectious Diseases ANRS/MIE</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>RP91168</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11706605</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>The SARS-CoV-2 main protease (M&lt;sup>pro&lt;/sup> or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 M&lt;sup>pro&lt;/sup>. TRMT1 installs the &lt;i>N&lt;/i>&lt;sup>2&lt;/sup>,&lt;i>N&lt;/i>&lt;sup>2&lt;/sup>-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that M&lt;sup>pro&lt;/sup> can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1</pubmed_abstract><journal>eLife</journal><pubmed_title>Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease.</pubmed_title><pmcid>PMC11706605</pmcid><funding_grant_id>P20 GM104316</funding_grant_id><funding_grant_id>T32 GM133395</funding_grant_id><funding_grant_id>ANR-20-CE15-0020-01</funding_grant_id><funding_grant_id>S10 OD026896A</funding_grant_id><funding_grant_id>ECTZ118944</funding_grant_id><funding_grant_id>R35 GM127040</funding_grant_id><funding_grant_id>R35 GM143000</funding_grant_id><pubmed_authors>D'Oliviera A</pubmed_authors><pubmed_authors>Mottaghinia S</pubmed_authors><pubmed_authors>Etienne L</pubmed_authors><pubmed_authors>Geissler EP</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Olson S</pubmed_authors><pubmed_authors>Mugridge JS</pubmed_authors><pubmed_authors>Dai X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease.</name><description>The SARS-CoV-2 main protease (M&lt;sup>pro&lt;/sup> or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 M&lt;sup>pro&lt;/sup>. TRMT1 installs the &lt;i>N&lt;/i>&lt;sup>2&lt;/sup>,&lt;i>N&lt;/i>&lt;sup>2&lt;/sup>-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that M&lt;sup>pro&lt;/sup> can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T17:28:42.062Z</modification><creation>2026-04-18T03:11:45.689Z</creation></dates><accession>S-EPMC11706605</accession><cross_references><pubmed>39773525</pubmed><doi>10.7554/eLife.91168</doi></cross_references></HashMap>